NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to developing innovative ...

NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to developing innovative ...

Stifel Nicolaus analyst Justin Keywood maintained a Buy rating on Cipher Pharmaceuticals (CPHRF – Research Report) today and set a price ...

Stifel Nicolaus analyst Justin Keywood maintained a Buy rating on Savaria (SIS – Research Report) today and set a price target of ...

New York, New York--(Newsfile Corp. - September 6, 2024) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of ...

Gains in pharmaceutical and healthcare stocks such as Glenmark Lifesciences, Suven Pharma, others helped contain broader market losses on September 6 as investors showed buying interest in the ...

US clinical stage CNS drug developer Athira Pharma (Nasdaq: ATHA) saw its share crash 78.4% to $0.61 yesterday, after it announced another disappoint with its Alzheimer’s candidate. Athira released ...

Historically, pharmaceutical products have been produced in a traditional ‘batch’ system, in which every operation is executed separately using a defined quantity of materials. In batch ...

Mankind Pharma Ltd, India's fourth-largest pharmaceutical company by market share, is set to raise over Rs 9,000 crore through a strategic mix of non-convertible debentures (NCDs) and short-term ...

Emmy award-winning investigative reporter and New York Times bestselling author Sharyl Attkisson makes her case in her new book "Follow The Science: How Big Pharma Misleads, Obscures, and Prevails." ...

What is the current share price of Mayne Pharma Group Limited (MYX)? Mayne Pharma Group Limited's (MYX) current share price is $5.25. This constitutes a price movement of 33.25% when compared to the ...